Abstract
The 22q11.2 deletion syndrome is characterized by great clinical heterogeneity among patients, and this heterogeneity does not seem to be related to the classes of more frequent deletion sizes (3 Mb, 1.5 Mb and atypical deletions). Thus, although the dose-sensitive genes mapped in the deleted region are important candidates for the phenotype, it has been suggested that more complex molecu…